UIA
IRON icon

Ulland Investment Advisors’s Disc Medicine IRON Stock Holding History

Ulland Investment Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-34
Closed -$2K – 220
2023
Q3 		$2K Hold
34
– – ﹤0.01% 199
2023
Q2 		$2K Hold
34
– – ﹤0.01% 200
2023
Q1 		$1K Hold
34
– – ﹤0.01% 197
2022
Q4 		$1K Buy
34
+22
+183% +$1.1K ﹤0.01% 205
2022
Q3 		$1K Hold
12
– – ﹤0.01% 208
2022
Q2 		$1K Hold
12
– – ﹤0.01% 236
2022
Q1 		$0 Hold
12
– – ﹤0.01% 268
2021
Q4 		$1K Buy
+12
New +$1.18K ﹤0.01% 210

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ulland Investment Advisors's IRON Position: Q4 2023 in Review

Ulland Investment Advisors sold out of Disc Medicine (IRON) in Q4 2023, closing a stake of 34 shares — an estimated $2K sold.

Ulland Investment Advisors first reported a position in IRON in Q4 2021 and held it in 8 quarters. The position peaked at $2K in Q3 2023. 112 funds tracked by Wall St. Rank hold IRON as of Q4 2023.

  • Ulland Investment Advisors reported no remaining Disc Medicine position as of Q4 2023 after selling out during the quarter.
  • Ulland Investment Advisors sold 34 Disc Medicine shares in Q4 2023, an estimated $2K.
  • Ulland Investment Advisors first reported a position in Disc Medicine in Q4 2021 and held it in 8 quarters.
  • Ulland Investment Advisors's Disc Medicine position peaked at $2K in Q3 2023.
  • 112 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2023.

Based on Ulland Investment Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.